Corey Lab Group

Our Research

Welcome to the Corey Lab. Our lab focuses on the pathogenesis of chronic viral infections and host immune responses. This includes herpes simplex virus type 2 (HSV-2) and HIV, and most recently SARS-CoV-2. We use HSV as a model to study the tissue based immune system of the genital tract. Our studies indicate a diverse and unique set of tissue resident cells populate the genital tract and our work is devoted to identifying and understanding the role of these cells in disease pathogenesis. The ultimate goal for these projects is to develop immunotherapeutic methods to control subclinical HSV-2 reactivation and reduce the transmission to sexual partners. Our lab has also initiated several preclinical studies to use adoptive transfer of genetically engineered T cells (CAR T cells) to traffic to and be effectors in lymphoid follicles with a goal to eradicate HIV infections.

Publications

Nature Medicine 2025

How HIV research drives health innovation in multiple diseases.

Corey L, Ratevosian J, Beyrer C, Currier J, Eron J, Cohen MS, Deeks SG

JCI Insight 2024

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine. 

Ford ES, Li AZ, Laing KJ, Dong L, Diem K, Jing L, Mayer-Blackwell K, Basu K, Ott M, Tartaglia J, Gurunathan S, Reid JL, Ecsedi M, Chapuis AG, Huang ML, Magaret AS, Johnston C, Zhu J, Koelle DM, Corey L. 

Journal of Clinical Investigation 2024

Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers. 

Eichholz K, Fukazawa Y, Peterson CW, Haeseleer F, Medina M, Hoffmeister S, Duell DM, Varco-Merth BD, Dross S, Park H, Labriola CS, Axthelm MK, Murnane RD, Smedley JV, Jin L, Gong J, Rust BJ, Fuller DH, Kiem HP, Picker LJ, Okoye AA, Corey L.

Recent News